Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HCI Group, Inc.HCI · Entity 4402 | Director | June 04, 2020 | June 08, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HCI Group, Inc.
Report date June 04, 2020 · Filed June 08, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 524 |
Reported balance
After 2020-06-04 transaction · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · 2020-06-04 · Grant · Acquired 524 · Balance 524 F2: Restricted stock grant of 524 shares effective 6/4/2020: The restricted shares will vest on 5/24/2021. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 6/4/2020. |
| Common StockSEC Table I · non-derivative | Direct | 106,080 |
Reported balance
Holding disclosure · report date 2020-06-04 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 106,080 F1: Shares are held jointly with spouse. |
| Common StockSEC Table I · non-derivative | Direct | 593 |
Reported balance
Holding disclosure · report date 2020-06-04 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 593 |
Filing footnotes · ownership attribution and instrument terms
F1: Shares are held jointly with spouse.
F2: Restricted stock grant of 524 shares effective 6/4/2020: The restricted shares will vest on 5/24/2021. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 6/4/2020.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
BayFirst Financial Corp.
Report date December 12, 2022 · Filed December 19, 2022
Section 16 reporting ended · disclosed 2022-12-19. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.67 · Expires 2031-01-14 | Direct | 1,250 |
Reported balance
After 2022-12-12 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-12-12 · Other · Disposed 2,500 · Balance 1,250 F4: Non-vested options were forfeited with resignation from Board of Directors. Vested options may be exercised for 12 months from resignation date. F5: These options vested in three equal annual installments beginning one year after the 1/14/2021 date of grant. F2: Options are exercisable for 12 months after resignation date of December 12, 2022. |
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.67 · Expires 2030-01-15 | Direct | 2,600 |
Reported balance
After 2022-12-12 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-12-12 · Other · Disposed 1,300 · Balance 2,600 F4: Non-vested options were forfeited with resignation from Board of Directors. Vested options may be exercised for 12 months from resignation date. F6: These options vested in three equal annual installments beginning one year after the 1/15/2020 date of grant. F2: Options are exercisable for 12 months after resignation date of December 12, 2022. |
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.33 · Expires 2028-06-12 | Direct | 5,400 |
Reported balance
Holding disclosure · report date 2022-12-12 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 5,400 F1: These options vested in three equal annual installments beginning one year after the 6/12/2018 date of grant. F2: Options are exercisable for 12 months after resignation date of December 12, 2022. |
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.67 · Expires 2029-03-15 | Direct | 3,900 |
Reported balance
Holding disclosure · report date 2022-12-12 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 3,900 F3: These options vested in three equal annual installments beginning one year after the 3/15/2019 date of grant. F2: Options are exercisable for 12 months after resignation date of December 12, 2022. |
| Common StockSEC Table I · non-derivative | Direct | 87,169.46 |
Reported balance
Holding disclosure · report date 2022-12-12 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 87,169.46 |
Filing footnotes · ownership attribution and instrument terms
F1: These options vested in three equal annual installments beginning one year after the 6/12/2018 date of grant.
F2: Options are exercisable for 12 months after resignation date of December 12, 2022.
F3: These options vested in three equal annual installments beginning one year after the 3/15/2019 date of grant.
F4: Non-vested options were forfeited with resignation from Board of Directors. Vested options may be exercised for 12 months from resignation date.
F5: These options vested in three equal annual installments beginning one year after the 1/14/2021 date of grant.
F6: These options vested in three equal annual installments beginning one year after the 1/15/2020 date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 12, 2022 Filed Dec 19, 2022 19:57 UTC | BayFirst Financial Corp. BAFN · Entity 6302 | OtherOption (Right to Buy) · Derivative | 1,300 | $0.00 Strike: $15.67 | $0.00 |
DisclosureSEC source: 0001649739-22-000378 · wf-form4_167147983262747.xml · derivative · entry 5 Apostolou George · CIK 0001439936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,600 Underlying: Common Stock · 1,300 shares Expires 2030-01-15 F4 · kind: Non-vested options were forfeited with resignation from Board of Directors. Vested options may be exercised for 12 months from resignation date. F6 · derivative.exercise_date: These options vested in three equal annual installments beginning one year after the 1/15/2020 date of grant. F2 · derivative.expiration_date: Options are exercisable for 12 months after resignation date of December 12, 2022. Read SEC document |
| December 12, 2022 Filed Dec 19, 2022 19:57 UTC | BayFirst Financial Corp. BAFN · Entity 6302 | OtherOption (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $14.67 | $0.00 |
DisclosureSEC source: 0001649739-22-000378 · wf-form4_167147983262747.xml · derivative · entry 4 Apostolou George · CIK 0001439936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Underlying: Common Stock · 2,500 shares Expires 2031-01-14 F4 · kind: Non-vested options were forfeited with resignation from Board of Directors. Vested options may be exercised for 12 months from resignation date. F5 · derivative.exercise_date: These options vested in three equal annual installments beginning one year after the 1/14/2021 date of grant. F2 · derivative.expiration_date: Options are exercisable for 12 months after resignation date of December 12, 2022. Read SEC document |
| January 27, 2022 Filed Jan 28, 2022 17:44 UTC | BayFirst Financial Corp. BAFN · Entity 6302 | GrantCommon Stock | 925 | $0.00 | $0.00 |
DisclosureSEC source: 0001439936-22-000001 · wf-form4_164339185133504.xml · nonDerivative · entry 1 Apostolou George · CIK 0001439936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,169.46 F1 · shares: Restricted stock award granted which will vest on the first anniversary of the grant date, subject to continued service through the applicable vesting date. Read SEC document |
| June 04, 2020 Filed Jun 8, 2020 16:12 UTC | HCI Group, Inc. HCI · Entity 4402 | GrantCommon Stock | 524 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-034954 · doc4.xml · nonDerivative · entry 3 Apostolou George · CIK 0001439936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 524 F2 · shares: Restricted stock grant of 524 shares effective 6/4/2020: The restricted shares will vest on 5/24/2021. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 6/4/2020. F2 · price: Restricted stock grant of 524 shares effective 6/4/2020: The restricted shares will vest on 5/24/2021. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 6/4/2020. F2 · balance_after: Restricted stock grant of 524 shares effective 6/4/2020: The restricted shares will vest on 5/24/2021. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 6/4/2020. Read SEC document |
| March 27, 2020 Filed Mar 31, 2020 16:01 UTC | HCI Group, Inc. HCI · Entity 4402 | PurchaseCommon Stock | 140 | $38.70 | $5,418.00 |
DisclosureSEC source: 0001209191-20-021789 · doc4.xml · nonDerivative · entry 2 Apostolou George · CIK 0001439936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,020 F1 · ownership.direct: Shares are held jointly with spouse. Read SEC document |
| March 27, 2020 Filed Mar 31, 2020 16:01 UTC | HCI Group, Inc. HCI · Entity 4402 | PurchaseCommon Stock | 60 | $38.73 | $2,323.80 |
DisclosureSEC source: 0001209191-20-021789 · doc4.xml · nonDerivative · entry 1 Apostolou George · CIK 0001439936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,080 F1 · ownership.direct: Shares are held jointly with spouse. Read SEC document |
| September 09, 2019 Filed Sep 11, 2019 16:05 UTC | HCI Group, Inc. HCI · Entity 4402 | GrantCommon Stock | 593 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-049130 · doc4.xml · nonDerivative · entry 2 Apostolou George · CIK 0001439936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 593 F2 · shares: Restricted stock grant of 593 shares effective 9/9/2019: The restricted shares will vest on 6/1/2020. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 9/9/2019. F2 · price: Restricted stock grant of 593 shares effective 9/9/2019: The restricted shares will vest on 6/1/2020. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 9/9/2019. Read SEC document |
| May 17, 2019 Filed May 21, 2019 15:40 UTC | HCI Group, Inc. HCI · Entity 4402 | OtherCommon Stock | 12,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-031702 · doc4.xml · nonDerivative · entry 2 Apostolou George · CIK 0001439936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: A restricted stock award of 24,000 shares was granted May 16, 2013 with the provision that any unvested shares would be forfeited six years and one day after the grant date. The award was divided into four tranches of 6,000 shares each for which vesting was dependent upon the Issuer's common stock meeting certain price levels. Of the 24,000 shares, a 6,000 share tranche vested in 2013 and a 6,000 share tranche was cancelled pursuant to an agreement on February 23, 2016. The remaining 12,000 shares were forfeited on May 17, 2019. These shares had been granted pursuant to the Issuer's 2012 Omnibus Incentive Plan. F2 · acquired: A restricted stock award of 24,000 shares was granted May 16, 2013 with the provision that any unvested shares would be forfeited six years and one day after the grant date. The award was divided into four tranches of 6,000 shares each for which vesting was dependent upon the Issuer's common stock meeting certain price levels. Of the 24,000 shares, a 6,000 share tranche vested in 2013 and a 6,000 share tranche was cancelled pursuant to an agreement on February 23, 2016. The remaining 12,000 shares were forfeited on May 17, 2019. These shares had been granted pursuant to the Issuer's 2012 Omnibus Incentive Plan. Read SEC document |
| December 05, 2018 Filed Dec 14, 2018 08:24 UTC | HCI Group, Inc. HCI · Entity 4402 | PurchaseCommon stock | 500 | $53.79 | $26,895.00 |
DisclosureSEC source: 0001209191-18-062556 · doc4.xml · nonDerivative · entry 1 Apostolou George · CIK 0001439936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,880 F1 · ownership.direct: Shares are held jointly with spouse. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.